Debemos hacer un esfuerzo para mejorar los indicadores de la UDES y es misión de todos publicar en Revistas de alta calidad académica.
PUBLICACIONES INCLUIDAS EN EL ANALISIS (2003-2010)
1. Lopez-Jaramillo P. Defining the research priorities to fight the burden of cardiovascular diseases in Latin America. Journal of Hypertension 2008; 26: 1886-188
2. Lopez-Jaramillo P, Arenas WD, Garcia RG, Rincon MY, Lopez M. The role of the L-arginine- nitric oxide pathway in preeclampsia. Therapeutic Advances in Cardiovascular Disease. 2008; 2: 261-275
3. Garcia RG, Lopez-Jaramillo P. Cardiovascular prevention in high-risk patients with type 2 diabetes mellitus: when to start it? European Hearth Journal 2008; 29:2058-2059
4. Lopez-Jaramillo P, Garcia G, Camacho P.A, Herrera E, Castillo V. Interrelationship between body mass index, C-reactive protein and blood pressure in a Hispanic pediatric population. American Journal of Hypertension 2008; 21: 527-532.
5. López-Jaramillo P , Silva S.Y, Rodríguez Salamanca N, Duran A, Mosquera W, Castillo V. Are Nutrition-Induced Epigenetic Changes the Link Between Socioeconomic Pathology and Cardiovascular Diseases? American Journal of Therapeutics 15, 2008; 15:362-372.
6. López-Jaramillo P, Herrera J.A, Arenas-Mantilla M, Jáuregui I.E, Mendoza M.A. Subclinical Infection as a Cause of Inflammation in Preeclampsia. American Journal of Therapeutics 15 2008;15: 373-376.
7. Lopez-Jaramillo P, Pradilla LP, Castillo V, Lahera V. Socioeconomical pathology as determinant of regional differences in the prevalence of metabolic syndrome and pregnancy-induced hypertension. Revista Española de Cardiología. 2007; 60: 168-178.
8. Silva SY , Rueda LC , Márquez GA , López M , Smith DJ , Calderón CA , Castillo JC , Matute J , Rueda-Clausen CF , Orduz A , Silva FA , Kampeerapappun P , Bhide M , López-Jaramillo P . Double blind, randomized, placebo controlled clinical trial for the treatment of diabetic foot ulcers, using a nitric oxide releasing patch: PATHON. Trials. 2007; 8: 26.
9. Herrera JA, Parra B, Herrera E, Botero JE, Arce RM, Contreras A, Lopez-Jaramillo P. Periodontal disease severity is related to high levels of C-reactive protein in pre-eclampsia. Journal of Hypertension 2007; 25: 1459-1464.
10. López-Jaramillo P, Pradilla LP, Lahera V, Silva F, Rueda-Clausen C, Marquez G. A randomized, double blind, cross-over, placebo-controlled clinical trial to assesss the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglycemia and abdominal obesity. ARAMIA. Trials 7: 28, 2006.
11. Silva S, Rueda LC, Lopez M, Velez ID, Rueda-Clausen CF, Smith DJ, Muñoz G, Mosquera H, Silva FA, Buitrago A, Diaz H , Lopez- Jaramillo P . Double blind, randomized controlled trial, to evaluate the effectiveness of a controlled nitric oxide releasing patch versus meglumine antimoniate in the treatment of cutaneous leishmaniasis (NCT00317629). Trials 7:14, 2006.
